Valeant Pharma (VRX), Walgreens Distribution Deal Structure Seen as 'Unusual'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
Valeant Pharmaceuticals (VRX) Guidance 'Probably Conservative' - BMO Capital
December 16, 2015 8:09 AM ESTBMO Capital analyst Alex Arfaei said after a first look at Valeant Pharmaceuticals (NYSE: VRX) guidance he views it at "probably conservative."
Arfaei commented, "While some components of the guidance may appear disappointing, we suspect that it is conservative. About 7.2% of... More
QLT, Inc. (QLTI) Files Breach of Contract Lawsuit Against ValeantPharma (VRX)
December 16, 2015 7:01 AM ESTQLT Inc. (NASDAQ: QLTI) announced that it has filed a breach of contract lawsuit against Valeant Pharmaceuticals International, Inc. (NYSE: VRX) in the Supreme Court of British Columbia. QLT alleges that Valeant has failed to pay the $5 Million laser... More
Valeant Pharma (VRX) Trims Q4, FY15 Outlook; Offers FY16 Guidance
December 16, 2015 6:04 AM ESTValeant Pharmaceuticals International, Inc. (NYSE: VRX) announced updated financial guidance for the fourth quarter and full year 2015 as well as new guidance for full year 2016.
"We are very excited about the strong future given our broad portfolio of brands, our upcoming launch products and our robust R&D pipeline," said J. Michael Pearson, chairman and chief executive officer. "We believe that we are entering a new era of growth and opportunity as we continue to build and grow our businesses around the world and deliver... More
